The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Jan. 17, 2020
Applicants:

Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, CN;

The Regents of the University of Michigan, Ann Arbor, MI (US);

Ascentage Pharma Group Corp Limited, Hong Kong, CN;

Inventors:

Jianyong Chen, Suzhou, CN;

Yunlong Zhou, Suzhou, CN;

Guozhi Tang, Suzhou, CN;

Chengzhe Wu, Suzhou, CN;

Leilei Zhao, Suzhou, CN;

Lingling Jiao, Suzhou, CN;

Binghua Sheng, Suzhou, CN;

Shaomeng Wang, Superior Township, MI (US);

Chao-Yie Yang, Ann Arbor, MI (US);

Hao Chen, Suzhou, CN;

Wenliang Hu, Suzhou, CN;

Yu Jing, Suzhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/20 (2006.01); C07D 515/20 (2006.01); C07D 498/08 (2006.01); A61K 31/553 (2006.01); A61P 35/00 (2006.01); C07D 513/10 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 513/20 (2013.01); A61P 35/00 (2018.01); C07D 513/10 (2013.01); C07D 519/00 (2013.01);
Abstract

Provided are compounds represented by Formula (I-A) and the pharmaceutically acceptable salts and solvates thereof, wherein R, R, R, R, R, X, Y, Z, Z, W, and (aa) are as defined as set forth in the specification. Provided are also compounds of Formula (I-A) for use to treat a condition or disorder responsive to Mcl-1 inhibition such as cancer.


Find Patent Forward Citations

Loading…